<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, a risk factor for esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, is associated with reflux disease </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to assess the expression of <z:chebi fb="0" ids="3098">bile acid</z:chebi> receptors in the esophagus (<z:mpath ids='MPATH_458'>normal</z:mpath>, <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>) and to investigate their possible function </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: the expression of the <z:chebi fb="0" ids="3098">bile acid</z:chebi> receptors FXR and VDR in esophageal biopsies from patients with a <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa, <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 6 per group) and in cell lines derived from <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, was assessed by real time Q-PCR and immunohistochemistry </plain></SENT>
<SENT sid="3" pm="."><plain>The effect of guggulsterone, an <z:chebi fb="68" ids="48706">antagonist</z:chebi> of <z:chebi fb="0" ids="3098">bile acid</z:chebi> receptors, on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>-derived cells was assessed morphologically, by flow cytometry and by measuring caspase 3 activity </plain></SENT>
<SENT sid="4" pm="."><plain>The expression of FXR was increased in <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> compared to <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa by a mean of 44, 84 and 16, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Immunohistochemistry showed a weak expression in <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus, a strong focal reactivity in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and was negative in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>VDR expression did not significantly differ between groups </plain></SENT>
<SENT sid="7" pm="."><plain>In cell cultures, the expression of FXR was high in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>-derived cells and almost undetectable in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>-derived cells, whereas VDR expression in these cell lines was not significantly different </plain></SENT>
<SENT sid="8" pm="."><plain>In vitro treatment with guggulsterone was associated with a significant increase in the percentage of apoptotic cells and of the caspase 3 activity </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: the <z:chebi fb="0" ids="3098">bile acid</z:chebi> receptor FXR is significantly overexpressed in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> compared to <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa, <z:hpo ids='HP_0100633'>esophagitis</z:hpo> and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>The induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by guggulsterone in a <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>-derived cell line suggests that FXR may contribute to the regulation of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>